Given that MTF2 restoration in our rescue experiments reversed the oncogenic effects of PCIF1 knockdown, targeting the PCIF1‐MTF2 axis could offer a promising therapeutic strategy, not only in OSCC but also in other cancers where this pathway is dysregulated. This evidence concerns the gene PCIF1 and cancer.